Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.
J Clin Med
; 11(3)2022 Jan 26.
Article
in En
| MEDLINE
| ID: mdl-35160081
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Year:
2022
Type:
Article